Citation Impact

Citing Papers

Chromosomal Instability Confers Intrinsic Multidrug Resistance
2011
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
2010
RNA-Guided Human Genome Engineering via Cas9
2013 StandoutScience
Examining the link between chromosomal instability and aneuploidy in human cells
2008
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer.
2013
Mitotic and mitogenic Wnt signalling
2012
CD4+ Tregs and immune control
2004 StandoutNobel
Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts
2006 StandoutNobel
Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer
2013
Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case–control study in Japan
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
2017
Metastatic tumor evolution and organoid modeling implicate TGFBR2as a cancer driver in diffuse gastric cancer
2014
Transforming growth factor-β in T-cell biology
2002
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice
2004
Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress
2010 StandoutNobel
Bioluminescent imaging of Cdk2 inhibition in vivo
2004 StandoutNobel
A Robust Approach to Identifying Tissue-Specific Gene Expression Regulatory Variants Using Personalized Human Induced Pluripotent Stem Cells
2009
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
2007
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
2003 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions
2003
Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice
2006
Post-transcriptional gene regulation by mRNA modifications
2016 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Cellular ligands of activating NK receptors
2005
Classification of chromosome segregation errors in cancer
2008
Imaging in the era of molecular oncology
2008 StandoutNature
Lung Cancer
2008 Standout
Regulation of cell proliferation by Smad proteins
2002
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness
2006
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
2004 Nature
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
2011 StandoutNature
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
2008
TGFβ: the molecular Jekyll and Hyde of cancer
2006
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint
2002
Dynamic RNA Modifications in Gene Expression Regulation
2017 Standout
Targeting tumours with genetically enhanced T lymphocytes
2003
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Inflammation and Colon Cancer
2010 Standout
Human DNA damage response and repair deficiency syndromes: Linking genomic instability and cell cycle checkpoint proficiency
2009
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
A Translational View of the Molecular Pathogenesis of Lung Cancer
2007
Immunity, Inflammation, and Cancer
2010 Standout
Whole Chromosome Instability Caused by Bub1 Insufficiency Drives Tumorigenesis through Tumor Suppressor Gene Loss of Heterozygosity
2009
Genome stability is ensured by temporal control of kinetochore–microtubule dynamics
2008
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Genetic predisposition to colorectal cancer
2004
TGFβ in Cancer
2008 Standout
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
2011
Transforming growth factor beta (TGF-β) and inflammation in cancer
2009
The anaphase-promoting complex: it's not just for mitosis any more
2002
New insights into the aetiology of colorectal cancer from genome-wide association studies
2009
Aneuploidy Acts Both Oncogenically and as a Tumor Suppressor
2006
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex
2004 StandoutNatureNobel
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
N6-methyladenosine-dependent regulation of messenger RNA stability
2013 StandoutNature
The role of senescent cells in ageing
2014 StandoutNature
Clonal evolution in cancer
2012 StandoutNature
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Elastin is an essential determinant of arterial morphogenesis
1998 StandoutNature
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
2016 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Reversible RNA adenosine methylation in biological regulation
2012
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
The Tissue Microenvironment as an Epigenetic Tumor Modifier
2003
Modeling Development and Disease with Organoids
2016 Standout
Perioperative Normothermia to Reduce the Incidence of Surgical-Wound Infection and Shorten Hospitalization
1996 Standout
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
2008
Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint
2004
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
2010
Anticoagulation Monitoring during Cardiac Surgery 
1999
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Reversible Inhibition of Human Platelet Activation by Hypothermia In Vivo and In Vitro
1994
DNA Mismatch Repair:  Functions and Mechanisms
2005 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome
2004 StandoutNobel
New Insights into the Troubles of Aneuploidy
2012
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
Atg13 HORMA domain recruits Atg9 vesicles during autophagosome formation
2015 StandoutNobel
Structure and Thermodynamics of N6-Methyladenosine in RNA: A Spring-Loaded Base Modification
2015
Targeting the TGFβ pathway for cancer therapy
2014
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
TGF-β and cancer
2005
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
The Intima
1995

Works of Boris Pasche being referenced

Tgfbr1 Haploinsufficiency Inhibits the Development of Murine Mutant Kras -Induced Pancreatic Precancer
2009
Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer
2008 Science
Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development
2009
Thrombin-inhibitory capacity of the injured vessel wall
1991
Somatic Acquisition and Signaling of <EMPH TYPE="ITAL">TGFBR1</EMPH>*6A in Cancer
2005
Role of transforming growth factor beta in cancer
2001
Antitransforming growth factor-β therapy in fibrosis: recent progress and implications for systemic sclerosis
2008
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells
2001 Nature
Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk
2011
TGF-β Signaling Alterations and Colon Cancer
2010
No major association between TGFBR1*6A and prostate cancer.
2004
The role of the fat mass and obesity associated gene (FTO) in breast cancer risk
2011
TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
2014
TGF-β signaling alterations and susceptibility to colorectal cancer
2007
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.
1998
Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq
2019
Role of TGF-β in cancer and the potential for therapy and prevention
2004
Combined Genetic Assessment of Transforming Growth Factor-β Signaling Pathway Variants May Predict Breast Cancer Risk
2005
Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk
2008
TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies
2004
The platelet function defect of cardiopulmonary bypass [see comments]
1993
TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies
2003
TGFBR1☆6A May Contribute to Hereditary Colorectal Cancer
2005
Rankless by CCL
2026